human c1 esterase inhibitor

Poland

Drugs containing this active substance

  • BERINERT 1500

    The medicine is used to treat and prevent the occurrence of swelling (edema) during procedures in individuals suffering from hereditary angioedema type I and II.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    human c1 esterase inhibitor 450-625 IU/ml

    ATC: B02AB03

    Manufacturer: CSL Behring GmbH

  • The medicinal product is used for the prevention of recurrent attacks of hereditary angioedema (HAE) in adolescents and adults.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    human c1 esterase inhibitor 2000 j.m.

    ATC: B06AC01

    Manufacturer: CSL Behring GmbH

  • The medicine is used for protection against recurrent attacks of hereditary angioedema (HAE) in adolescents and adults.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    human c1 esterase inhibitor 3000 j.m.

    ATC: B06AC01

    Manufacturer: CSL Behring GmbH

  • The medicine is used to treat and prevent the occurrence of swelling (edema) during procedures in people suffering from hereditary angioedema type I and II (HAE).

    Form: solution for injection or infusion, powder and solvent for preparation of

    Active substance Dosage
    human c1 esterase inhibitor 40.0 - 62.5 J/ml

    ATC: B06AC01

    Manufacturer: CSL Behring GmbH